This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Stay Ahead of the Game With ProAssurance (PRA) Q4 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for ProAssurance (PRA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
ProAssurance (PRA) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
ProAssurance (PRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
First American Financial (FAF) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
First American Financial (FAF) delivered earnings and revenue surprises of 26.17% and 2.78%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
ALL to Sell Group Health Unit, Intensifies Focus on Core Operations
by Zacks Equity Research
Allstate is set to divest its Group Health business to Nationwide for $1.25 billon. This divesture is likely to boost deployable capital by $0.9 billion while adversely impacting the insurer's ROE by 75 bps.
Synchrony Collaborates With Pet Paradise, Expands CareCredit Offering
by Zacks Equity Research
SYF's partnership with Pet Paradise is expected to expand the financing options for pet parents looking for affordable services like boarding stays and dog training.
FAF Rises 17% in 6 Months: Time to Buy the Stock for Solid Returns?
by Zacks Equity Research
First American remains well-poised for growth on new business opportunities, increased exposures, a better renewal rate environment and effective capital deployment.
Here's Why You Should Invest in Virtu Financial Stock Now
by Zacks Equity Research
VIRT's strong market-making and execution services segment, along with its strong capital position, bode well.
Here's Why Investors Should Hold on to AON Stock Right Now
by Zacks Equity Research
Robust retention, new business and strategic acquisitions bode well for AON's growth.
Here's Why You Should Add CNO Financial to Your Portfolio Now
by Zacks Equity Research
CNO remains well-poised for growth on a diversified product portfolio, new product launches, technology investments and prudent capital deployment efforts.
Factors That Make Lincoln National Stock a Lucrative Bet Now
by Zacks Equity Research
LNC remains well-poised for growth on higher spread income, a well-performing Group Protection unit and a sustained record of returning value to shareholders.
3 Financial Stocks to Secure Your Investments Before Year-End
by Debasmita Chatterjee
Finance stocks are expected to reap the benefits of technology advancements, growing premiums and favorable consumer spending as they head into 2025. However, inflationary challenges might act as a partial offset.
Synchrony Collaborates With Daybreak, Expands CareCredit Offering
by Zacks Equity Research
SYF's partnership with Daybreak is set to provide financing options for customers who want to control their sleep health.
Aon's Renewal of Aon Client Treaty Expands Insurance Capacity
by Zacks Equity Research
AON announces the renewal of its Client Treaty for 2025. Higher insurance capacity should help attract new clients.
Aflac Approves a 16% Dividend Hike, Boosts Shareholder Value
by Zacks Equity Research
AFL raises its quarterly dividend to 58 cents per share, indicating a strong financial position and prudent capital deployment initiatives.
Here's Why Investors Should Hold Marsh & McLennan Stock for Now
by Zacks Equity Research
MMC is currently aided by strong segmental contribution, solid retention rates and tactical deployment of capital.
Zacks.com featured highlights include Sprouts Farmers, ProAssurance, Stride and Calavo Growers
by Zacks Equity Research
Sprouts Farmers, ProAssurance, Stride and Calavo Growers have been highlighted in this Screen of The Week article.
Buy 4 Low-Beta Stocks SFM, PRA, LRN, CVGW to Beat Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to navigate a volatile market. SFM, PRA, LRN, CVGW are well-poised to gain.
NMI Holdings Stock Rises 39.5% in a Year: More Room for Growth?
by Zacks Equity Research
NMIH stock rallies on the back of higher new insurance written volume, comprehensive reinsurance program, solid capital position and prudent capital deployment.
Discover Financial Unites With Telered, Enhances Payment Acceptance
by Zacks Equity Research
DFS and Telered enter into a strategic alliance to enhance acceptance of their cards and improve the cardholder experience.
Allstate Unveils Flexible Healthcare Solutions With Key Partnerships
by Zacks Equity Research
ALL partners with Thatch, Intuit QuickBooks and Ambetter Health to provide flexible healthcare solutions for customers.
First American Stock Near 52-Week High: Is This Your Buy Signal?
by Zacks Equity Research
FAF gains from new business opportunities, increased exposures, a better renewal rate environment and effective capital deployment.
ProAssurance Q3 Earnings Beat on Strong Net Investment Income
by Zacks Equity Research
PRA's third-quarter earnings benefit from improving underwriting results in its Specialty P&C segment. Declining profits in the Segregated Portfolio Cell Reinsurance unit partially offset the positives.
ProAssurance (PRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for ProAssurance (PRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ProAssurance (PRA) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ProAssurance (PRA) delivered earnings and revenue surprises of 183.33% and 2.77%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
NMI Holdings (NMIH) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
NMI Holdings (NMIH) delivered earnings and revenue surprises of 4.55% and 0.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?